newsfilter
← Latest News
GlobeNewswire·

Incannex Strengthens Clinical Development Pathway for IHL-42X Following Positive Phase 2 Outcomes

MELBOURNE, Australia and NEW YORK, March 12, 2026 (GLOBE NEWSWIRE) -- Incannex Healthcare Inc. (NASDAQ:IXHL), a clinical-stage biopharmaceutical company developing innovative combination therapies, today announced an